JP2013535009A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535009A5
JP2013535009A5 JP2013515555A JP2013515555A JP2013535009A5 JP 2013535009 A5 JP2013535009 A5 JP 2013535009A5 JP 2013515555 A JP2013515555 A JP 2013515555A JP 2013515555 A JP2013515555 A JP 2013515555A JP 2013535009 A5 JP2013535009 A5 JP 2013535009A5
Authority
JP
Japan
Prior art keywords
prpk
agent
tprkb
test agent
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013515555A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535009A (ja
JP5857043B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/040918 external-priority patent/WO2011160042A2/en
Publication of JP2013535009A publication Critical patent/JP2013535009A/ja
Publication of JP2013535009A5 publication Critical patent/JP2013535009A5/ja
Application granted granted Critical
Publication of JP5857043B2 publication Critical patent/JP5857043B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013515555A 2010-06-18 2011-06-17 Ｐｒｐｋ−ｔｐｒｋｂモジュレーター及びその使用 Expired - Fee Related JP5857043B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35655410P 2010-06-18 2010-06-18
US61/356,554 2010-06-18
PCT/US2011/040918 WO2011160042A2 (en) 2010-06-18 2011-06-17 Prpk-tprkb modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2013535009A JP2013535009A (ja) 2013-09-09
JP2013535009A5 true JP2013535009A5 (enExample) 2014-07-10
JP5857043B2 JP5857043B2 (ja) 2016-02-10

Family

ID=45348903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013515555A Expired - Fee Related JP5857043B2 (ja) 2010-06-18 2011-06-17 Ｐｒｐｋ−ｔｐｒｋｂモジュレーター及びその使用

Country Status (5)

Country Link
US (1) US9193989B2 (enExample)
EP (1) EP2582836B1 (enExample)
JP (1) JP5857043B2 (enExample)
ES (1) ES2664872T3 (enExample)
WO (1) WO2011160042A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013089278A1 (en) * 2011-12-14 2013-06-20 Taiho Pharmaceutical Co., Ltd. Recombinant prpk-tprkb and uses thereof
MX369709B (es) * 2013-03-15 2019-11-19 Univ Pennsylvania Vacunación mejorada contra tirosinasa.
CN105440014B (zh) * 2014-08-29 2018-08-28 杭州和泽医药科技有限公司 一种来那度胺的制备方法
NZ731789A (en) 2014-10-30 2019-04-26 Kangpu Biopharmaceuticals Ltd Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
US10302644B2 (en) * 2014-11-04 2019-05-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating multiple myeloma
WO2017176289A1 (en) * 2016-04-08 2017-10-12 Celgene Corporation Uses of lenalidomide and car t-cells
CN108101887A (zh) * 2016-11-24 2018-06-01 天津和美生物技术有限公司 哌啶-2,6-二酮衍生物及其在治疗克罗恩氏病中的用途
WO2018227129A1 (en) * 2017-06-09 2018-12-13 Regents Of The University Of Minnesota Skin care formulations and skin cancer treatment
TWI689501B (zh) * 2017-08-21 2020-04-01 諾瑞特國際藥業股份有限公司 泊馬度胺衍生物及其製備方法
WO2019036839A1 (zh) * 2017-08-21 2019-02-28 诺瑞特国际药业股份有限公司 泊马度胺衍生物及其制备方法
AU2019381688A1 (en) 2018-11-13 2021-06-03 Biotheryx, Inc. Substituted isoindolinones
CN111434659A (zh) * 2019-01-11 2020-07-21 南京诺瑞特医药科技有限公司 泊马度胺前体药物的盐
CN111499610A (zh) * 2019-01-31 2020-08-07 南京诺瑞特医药科技有限公司 泊马度胺前体药物盐的多晶型物
US20240124459A9 (en) * 2020-06-29 2024-04-18 Dana-Farber Cancer Institute, Inc. Prpk inhibitors

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5635517B1 (en) 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines
US6281230B1 (en) 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US6045501A (en) 1998-08-28 2000-04-04 Celgene Corporation Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
US6315720B1 (en) 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US20070134261A1 (en) * 2001-12-03 2007-06-14 Hancock Robert E Effectors of innate immunity
US7189740B2 (en) 2002-10-15 2007-03-13 Celgene Corporation Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
UA83504C2 (en) 2003-09-04 2008-07-25 Селджин Корпорейшн Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
CA2808646C (en) * 2003-09-17 2016-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
KR20060124607A (ko) 2003-11-06 2006-12-05 셀진 코포레이션 암 및 그 밖의 질환의 치료 및 관리를 위하여탈리도마이드를 사용하는 방법 및 조성물

Similar Documents

Publication Publication Date Title
JP2013535009A5 (enExample)
JP2011137045A5 (enExample)
JP2015536446A5 (enExample)
JP2014526065A5 (enExample)
EP2262911A4 (en) COMPOSITIONS, PROCESSES AND KITS WITH SYNTHETIC PROBES FOR DETECTING THE PRESENCE OF A TARGET NUCLEIC ACID
EP2253713A4 (en) METHOD FOR MEASURING COPY COUNTS OF CHROMOSOMES, GENES OR SPECIFIC NUCLEOTIDE SEQUENCES WITH THE AID OF AN SNP ARRAY
IN2014DN04226A (enExample)
BR112014003380A2 (pt) sistema e método para correção de aderência e deslizamento
JP2011207878A5 (enExample)
JP2011227454A5 (enExample)
EP2684062A4 (en) FABRIC-BASED FUNCTION TEST ACCESS MECHANISM FOR SOC
JP2011213717A5 (enExample)
DK2718293T3 (da) Substituerede pyridopyraziner som hidtil ukendte syk-inhibitorer
WO2013144342A3 (fr) Procede et dispositif de localisation d'un objet magnetique
MX378154B (es) Silanos y composiciones curables que comprenden dichos silanos.
JP2013534909A5 (enExample)
PE20141046A1 (es) Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria
JP2013523912A5 (enExample)
EP2464737A4 (en) INDIVIDUAL AND MULTI-TEMPERATURE PROCESSES, KITS AND COMPOUNDS FOR NUCLEIC ACID RECOGNITION
BR112012026545A2 (pt) composições e métodos para tratar exacerbação de copd
EA201290948A1 (ru) МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ
JP2011245846A5 (enExample)
JP2006508326A5 (enExample)
BR112013031048A2 (pt) método de adaptação de um composto de assinatura de um fenótipo que é derivado a partir de medições da amostra; aparelho de imagem clínica para a adaptação de uma assinatura composta de um fenótipo que é derivado de medições de uma amostra; elemento do programa para a adaptação de uma assinatura composta de um fenótipo; meio de leitura por computador
WO2006089185A8 (en) Pharmacogenomic markers for prognosis of solid tumors